Daniel Seth Fierer, M.D.


  1. Bajaj SP, Rapaport SI, Fierer DS, Herbst KD, Schwartz DB. A Mechanism for the Hypoprothrombinemia of the Acquired Hypoprothrombinemia-lupus Anticoagulant Syndrome. Blood 1983, 61(4):684-92
  2. Fierer DS, Challberg MD. Purification and Characterization of UL9, the Herpes Simplex Virus Type 1 Origin-Binding Protein. J. Virol. 1992, 66(7):3986-3995.
  3. Fierer DS, Challberg MD. The Stoichiometry of Binding of the Herpes Simplex Virus Type 1 Origin Binding Protein, UL9, to oriS. J. Biol. Chem. 1995, 270(13):7330-7334
  4. Kaplan G, Thomas S, Fierer DS, Mulligan K, Haslett PAJ, Fessel WJ, Smith LG, Kook KA, Stirling D, and Schambelan M. Thalidomide for the treatment of AIDS-associated wasting. AIDS Res. Hum. Retroviruses 2000, 16(14):1345-1355.
  5. Schwartz EJ, Fierer DS, Neumann AU, Keller MJ, Parkas V, Zhang DY, Klotman ME, Winston JA, and Klotman PE. HIV-1 dynamics in haemodialysis patients. AIDS 2002, 16:1301-1303.
  6. Fierer DS, Vargas J Jr., Patel N, Clover G. Absence of erythrocyte-assicated HIV-1 in vivo. J Infect. Dis. 2007; 196:587-590.
  7. Fierer DS, Uriel AJ, Carriero DC, Klepper A, Dieterich DT, Mullen MP, Thung SN, Fiel MI, and Brach AD. Liver fibrosis in an outbreak of acute CHV in HIV-infected men: a prospective cohort study. J. Infect. Dis. 2008; 198:683-686.


Technical and Strategic Consulting to the Pharmaceutical Industry. | ©2009 Salamandra, LLC